Home › Geographic Atrophy › Ohio › Cleveland
Geographic Atrophy clinical trials in Cleveland, OH
6 studies for Geographic Atrophy are looking for participants at sites in and around Cleveland (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Cleveland Clinic Main Campus, Cleveland
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RecruitingPhase 1/2
- Retina Associates of Cleveland, Cleveland
- Retina Associates of Cleveland - Beachwood, Beachwood · 10 mi away
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- University Hospitals Cleveland Medical Center, Cleveland
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- Cleveland Clinic Foundation-Cole Eye Institute, Cleveland
Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration
Recruiting
- Retina Associates of Cleveland, Beachwood · 10 mi away
Multicenter Clinical Study of the SING-IMT in Patients with Late-stage AMD
Recruiting
- Cleveland Clinic | Cole Eye Institute, Cleveland
Geographic Atrophy trials in other cities
- Dallas, TX8 studies
- Reno, NV8 studies
- Austin, TX7 studies
- Santa Monica, CA7 studies
- Houston, TX6 studies
- The Woodlands, TX6 studies
- Naperville, IL6 studies
- Baltimore, MD6 studies
- Spokane, WA5 studies
- Washington, DC5 studies
- Hagerstown, MD5 studies
- St. Louis, MO5 studies
Other studies in Cleveland
- Non-Small Cell Lung Cancer43 studies
- Cancer (all types)36 studies
- Breast Cancer35 studies
- Prostate Cancer34 studies
- Heart Failure33 studies
- Metastatic Cancer30 studies
- Ovarian Cancer30 studies
- Lung Cancer26 studies
- Colorectal Cancer24 studies
- Cardiovascular Disease22 studies
- Endometrial Cancer20 studies
- Acute Myeloid Leukemia20 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.